Curt, Armin, MD
Zurich, Canton of Zurich, 8008, Switzerland
NCT Number: NCT02138344
Development of neuropathic pain is one of the most disabling sequels after spinal cord injury (SCI) and in peripheral nerve diseases. The functionality of the pain pathway in humans as well as its plastic changes following SCI can be assessed in vivo by surface electrophysiological recordings and functional magnetic resonance imaging after noxious heat stimulation of the skin. Aims: a) establishing a clinically applicable assessment of the pain pathway and characterizing its changes as a consequence of SCI and in peripheral nerve diseases in an objective manner, b) characterizing plastic changes in the pain pathway in SCI patients with neuropathic pain and in patients with peripheral nerve diseases and relating them to the development of neuropathic pain syndromes.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Zurich, Canton of Zurich, 8008, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 - 4 weeks
University of Zurich
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01037088
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Sacramento, California, United States
View Trial DetailsNCT06330181
Central Nervous System Diseases, Nervous System Diseases
College Station, Texas, United States
View Trial DetailsNCT05777499
Acquired Brain Injury, Autoimmune Diseases
London, United Kingdom
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial Details